Dishman Pharmaceuticals and Chemicals rose 2.90% to Rs 353.50 at 9:26 IST on BSE after the company said that it fixed 3 May 2016 as the record date for the purpose of 1:1 bonus issue of shares.
The announcement was made after market hours yesterday, 21 April 2016.
Meanwhile, the BSE Sensex was down 81.03 points, or 0.31%, to 25,799.35 .
On BSE, so far 39,000 shares were traded in the counter, compared with an average volume of 1.87 lakh shares in the past one quarter. The stock hit a high of Rs 354.70 and a low of Rs 349.80 so far during the day. The stock hit a 52-week high of Rs 419.70 on 4 November 2015. The stock hit a 52-week low of Rs 126.05 on 3 June 2015. The stock had underperformed the market over the past one month till 21 April 2016, rising 1.21% compared with 2.35% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 11.96% as against Sensex's 8% rise.
The small-cap company has an equity capital of Rs 16.14 crore. Face value per share is Rs 2.
On a consolidated basis, net profit of Dishman Pharmaceuticals and Chemicals rose 95.30% to Rs 46.93 crore on 0.87% decline in net sales to Rs 382.47 crore in Q3 December 2015 over Q3 December 2014.
Dishman Pharmaceuticals and Chemicals is the global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and manufacturing services. The products and services offered by the company spans from chemical development to commercial manufacture and supply of active pharmaceutical ingredients.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
